In 2009, Joshua S. Boger earned $5.00M in total compensation at Vertex Pharmaceuticals, including $373.41K salary and $1.58M in stock. Most recently acquired 2,188 shares in Jun 2017. Currently holds stock worth $209.92M. Has donated $253.70M in stock to charitable causes. Led Vertex Pharmaceuticals as CEO for 4 years.
Compensation History
Annual executive compensation data for Joshua S. Boger, including salary, bonuses, and stock awards.
Year
2009
Total Compensation
$5.00M
Salary
$373.41K
Bonus
$0.00
Other
$3.04M
Salary
$373.41KBoard Justification
The compensation philosophy aims to align executive compensation with company performance and market competitiveness, ensuring retention and motivation of key executives.
Bonus
$0.00Board Justification
Dr. Boger did not receive a bonus for 2009 performance as his employment terminated in May 2009.
Other Compensation
$3.04MBoard Justification
This includes a cash severance payment and other benefits provided under the transition agreement following his termination as CEO.
Restricted Stock
Board Justification
No stock was vested in 2009 as the stock grants were not specified to have vested during this year.
Performance Metrics
The performance metrics for determining compensation were based on company performance and individual contributions, although specific metrics for 2009 were not detailed.
Joshua S. Boger
Ex-CEO of Vertex Pharmaceuticals
Sector of Economy
Healthcare
CEO of Vertex Pharmaceuticals for
4 years 0 months (May 2005 - May 2009)
Previous Experience
Unknown
Other Vertex Pharmaceuticals CEOs
Holdings
Track Joshua S. Boger's stock holdings and portfolio value over time.
Total Stock Sold
$153.88M
$153.88M
1,569,375 VRTX shares
What if they kept their stock?
If Joshua S. Boger didn't sell their stock, today they would have:
Extra VRTX1,569,375 shares worth $714.82M.
This is 364.54% and $560.94M more than what they got when they sold the stock.
Charitable Transactions
557,000 shares
VRTX
Recent Charitable Transactions
80,000 shares
VRTX
Nov 19, 2015
Charity
41,000 shares
VRTX
May 19, 2015
Charity
2,500 shares
VRTX
Feb 25, 2015
Charity
14,000 shares
VRTX
May 22, 2013
Charity
80,000 shares
VRTX
May 7, 2013
Charity
100,000 shares
VRTX
Feb 28, 2013
Charity
Insider Trading
Joshua S. Boger's recent stock transactions, purchases, and sales filed with the SEC.
2,188 shares
VRTX
Jun 1, 2017
Received
$665.17K
VRTX at $83.15/share
Jan 11, 2017
Sale
$498.94K
VRTX at $76.76/share
Jan 4, 2017
Sale
$484.61K
VRTX at $74.56/share
Dec 29, 2016
Sale
$487.50K
VRTX at $75.00/share
Dec 21, 2016
Sale
$505.83K
VRTX at $77.82/share
Dec 14, 2016
Sale
$490.34K
VRTX at $75.44/share
Dec 7, 2016
Sale
$545.58K
VRTX at $83.94/share
Nov 30, 2016
Sale
$559.91K
VRTX at $86.14/share
Nov 23, 2016
Sale
$594.17K
VRTX at $91.41/share
Nov 16, 2016
Sale
Rivals
Compare Joshua S. Boger with competitor CEOs and industry peers.
Albert Bourla
CEO of Pfizer
2024 Compensation
Stock
$0.00
Salary
$1.80M
Bonus
$7.02M
Other
$996.06K
Total Holdings
$18.14M
Sundar Pichai
CEO of Alphabet Inc.
2024 Compensation
Stock
$51.70M
Salary
$2.02M
Bonus
$0.00
Other
$8.30M
Total Holdings
$399.66M
Andrew R. Jassy
CEO of Amazon
2024 Compensation
Stock
$38.48M
Salary
$365.00K
Bonus
$0.00
Other
$1.23M
Total Holdings
$2.14M
Stéphane Bancel
CEO of Moderna
2023 Compensation
Stock
$0.00
Salary
$1.58M
Bonus
$1.91M
Other
$1.07M
Total Holdings
$335.71M
David A. Ricks
CEO of Eli Lilly
2024 Compensation
Stock
$0.00
Salary
$1.69M
Bonus
$5.71M
Other
$351.69K
Total Holdings
$468.86M